Cite
MLA Citation
Gordon John Sampson Rustin et al.. “Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG).” International journal of gynecological cancer, vol. 21, no. 2, 2011, pp. 419–423. http://access.bl.uk/ark:/81055/vdc_100135544425.0x00002c